Test Price
2,800 AED✅ Home Collection Available
SUCLA2 Gene Mitochondrial DNA Depletion Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SUCLA2 لمتلازمة نضوب الحمض النووي الميتوكوندري (فحص الحمض النووي الجيني NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Clinical Summary
- Diagnostic Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection; VIP Mobile Phlebotomy available 8 AM–11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation from DHA‑licensed neurologist.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
الفحص الجيني لجين SUCLA2 لمتلازمة نضوب الحمض النووي الميتوكوندري في الإمارات يضمن دقة تشخيصية بنسبة 99.9% عبر مختبرات معتمدة آيزو 9001:2015، مع خدمات سحب منزلية فائقة الجودة على مستوى الدولة، وإرشاد سريري من استشاري أعصاب مرخص من هيئة الصحة بدبي، مما يمنحك الطمأنينة التي تستحقها.
Clinical Overview
The SUCLA2 gene NGS test detects pathogenic variants linked to mitochondrial DNA depletion syndrome type 5 (MTDPS5), a severe encephalomyopathic disorder often presenting in infancy with hypotonia, developmental regression, and methylmalonic aciduria. يفيد اختبار جين SUCLA2 في تأكيد التشخيص وتوجيه الإستشارة الوراثية للعائلات المعرضة للخطر.
| Feature | Our Test (Premium) | Conventional Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) with full gene coverage & variant validation | Sanger sequencing of a single exon or targeted panel |
| Diagnostic Precision | 99.9% Analytical Sensitivity, including deep intronic & CNV detection | ~95% sensitivity; may miss large deletions or deep intronic mutations |
| Turnaround Time | 3 to 4 Weeks (with pre‑test genetic counselling included) | 4–6 Weeks, often without genetic counselling support |
| Sample Collection | Paid Hospital‑Grade Home Collection; Blood, Extracted DNA, or one‑drop FTA card | In‑clinic venipuncture only |
| Post‑Test Guidance | Telephonic interpretation by DHA‑licensed neurologist | Report only; no clinical consultation |
Physician Insight & Safety Protocol
“As a clinician, I emphasize that a positive SUCLA2 result must be correlated with the child’s neurological and metabolic phenotype; a negative result does not exclude all mitochondrial disorders. Families should receive post‑test genetic counseling to understand recurrence risks and available supportive therapies. Please do not discontinue prescribed medications without consulting your doctor.” — Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Neurologist.
Medication Warning:
Do not discontinue any prescribed anti‑epileptic, metabolic, or dietary management medications prior to or after this test without explicit instruction from your treating physician.
Exclusion Criteria & ER Red Flags
- Active acute infection or septic shock – postpone home collection.
- Severe coagulopathy or ongoing anticoagulant therapy not disclosed during booking.
- Patients under 18 years without guardian‑signed informed consent (Minors require CDS Law 2026 compliant documentation).
- Emergency symptoms suggesting metabolic crisis (e.g., intractable vomiting, lethargy, seizures) warrant immediate hospital attendance, not home sample collection.
Frequently Asked Questions (Clinical Guidance)
1. What does the SUCLA2 genetic test detect, and when is it recommended?
Our NGS‑based SUCLA2 gene test detects pathogenic variants causing mitochondrial DNA depletion syndrome type 5, recommended for infants or children with hypotonia, developmental delay, and elevated methylmalonic acid.
يكتشف الاختبار الطفرات المسببة لمتلازمة نضوب الحمض النووي الميتوكوندري من النوع الخامس عند الرضع أو الأطفال الذين يعانون من نقص التوتر وتأخر النمو وارتفاع حمض الميثيل مالونيك.
2. How is the sample collected, and is home service available across the UAE?
A trained phlebotomist draws a small blood sample or collects a single drop on an FTA card during a pre‑scheduled home visit, available in all emirates from 8 AM to 11 PM with full cold‑chain handling.
يتم سحب عينة دم صغيرة أو قطرة واحدة على بطاقة FTA خلال زيارة منزلية مجدولة تشمل جميع الإمارات من الثامنة صباحاً وحتى الحادية عشرة مساءً مع سلسلة تبريد معتمدة.
3. Will my health insurance cover the 2800 AED cost, and how do I confirm?
We provide direct billing verification to major UAE insurers; simply send your insurance card via WhatsApp to +971 54 548 8731 to confirm coverage before booking the.
نوفر خدمة التحقق المباشر من التغطية التأمينية مع كبرى شركات التأمين في الإمارات؛ أرسل صورة بطاقة التأمين عبر واتساب إلى 971545488731 للتأكيد.
UAE Regulatory Compliance & Accreditation
• This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic testing and patient privacy. • Minors’ genetic testing is handled under CDS Law 2026; guardian consent and counselling are mandatory. • Personal health data is protected per UAE PDPL and ISO 9001:2015 certified processes (Cert: INT/EGQ/2509DA/3139). • Facility License: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians